{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:07:43Z","timestamp":1794744463845,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The P2X<jats:sub>7<\/jats:sub> receptor plays a significant role in microglial activation, and as a potential drug target, the P2X<jats:sub>7<\/jats:sub> receptor is also an interesting target in positron emission tomography. The current study aimed at the development and evaluation of a potent tracer targeting the P2X<jats:sub>7<\/jats:sub> receptor, to which end four adamantanyl benzamide analogues with high affinity for the human P2X<jats:sub>7<\/jats:sub> receptor were labelled with carbon-11. All four analogues could be obtained in excellent radiochemical yield and high radiochemical purity and molar activity, and all analogues entered the rat brain. [<jats:sup>11<\/jats:sup>C]SMW139 showed the highest metabolic stability in rat plasma, and showed high binding to the <jats:italic>h<\/jats:italic>P2X<jats:sub>7<\/jats:sub> receptor <jats:italic>in vivo<\/jats:italic> in a <jats:italic>h<\/jats:italic>P2X<jats:sub>7<\/jats:sub> receptor overexpressing rat model. Although no significant difference in binding of [<jats:sup>11<\/jats:sup>C]SMW139 was observed between post mortem brain tissue of Alzheimer\u2019s disease patients and that of healthy controls in <jats:italic>in vitro<\/jats:italic> autoradiography experiments, [<jats:sup>11<\/jats:sup>C]SMW139 could be a promising tracer for P2X<jats:sub>7<\/jats:sub> receptor imaging using positron emission tomography, due to high receptor binding <jats:italic>in vivo<\/jats:italic> in the <jats:italic>h<\/jats:italic>P2X<jats:sub>7<\/jats:sub> receptor overexpressing rat model. However, further investigation of both P2X<jats:sub>7<\/jats:sub> receptor expression and binding of [<jats:sup>11<\/jats:sup>C]SMW139 in other neurological diseases involving microglial activation is warranted.<\/jats:p>","DOI":"10.1038\/s41598-018-24814-0","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T13:20:35Z","timestamp":1524230435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9573-8558","authenticated-orcid":false,"given":"Bieneke","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle J.","family":"Vugts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane M.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Ory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J. M.","family":"Hoozemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam","family":"Beaino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther J. M.","family":"Kooijman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"van den Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Chishty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Dom\u00e9n\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Van der Perren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-916X","authenticated-orcid":false,"given":"Alessandro","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ger T.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Funke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rostislav V.","family":"Shevchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Baekelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Bormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kassiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1250-7656","authenticated-orcid":false,"given":"Albert D.","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"24814_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuropharm.2015.09.019","volume":"104","author":"E Beamer","year":"2016","unstructured":"Beamer, E. et al. Purinergic mechanisms in neuroinflammation: An update from molecules to behaviour. Neuropharmacology 104, 94\u2013104 (2016).","journal-title":"Neuropharmacology"},{"key":"24814_CR2","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/glia.23001","volume":"64","author":"A Bhattacharya","year":"2016","unstructured":"Bhattacharya, A. & Biber, K. The Microglial ATP-Gated Ion Channel P2X7 As a CNS Drug Target. GLIA 64, 1772\u20131787 (2016).","journal-title":"GLIA"},{"key":"24814_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11302-015-9493-0","volume":"12","author":"G Burnstock","year":"2016","unstructured":"Burnstock, G. P2X ion channel receptors and inflammation. Purinergic Signalling 12, 59\u201367 (2016).","journal-title":"Purinergic Signalling"},{"key":"24814_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/jlcr.3206","volume":"57","author":"B Janssen","year":"2014","unstructured":"Janssen, B. et al. Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [11C]A-740003 as a novel tracer of neuroinflammation. J. Labelled Compd. Radiopharm. 57, 509\u2013516 (2014).","journal-title":"J. Labelled Compd. Radiopharm."},{"key":"24814_CR5","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.bmcl.2015.03.021","volume":"25","author":"M Gao","year":"2016","unstructured":"Gao, M., Wang, M., Green, M. A., Hutchins, G. D. & Zheng, Q.-H. Synthesis of [11C]GSK1482160 as a new PET agent for targeting P2X7 receptor. Bioorg. Med. Chem. Lett. 25, 1965\u20131970 (2016).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"24814_CR6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2967\/jnumed.115.169995","volume":"57","author":"D Ory","year":"2016","unstructured":"Ory, D. et al. Preclinical evaluation of a P2X7 receptor selective radiotracer: positron emission tomography studies in a rat model with local overexpression of the human P2X7 receptor and in non-human primates. J. Nucl. Med. 57, 1436\u20131441 (2016).","journal-title":"J. Nucl. Med."},{"key":"24814_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2967\/jnumed.116.181354","volume":"58","author":"PR Territo","year":"2017","unstructured":"Territo, P. R. et al. Characterization of C-11-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation. J. Nucl. Med. 58, 458\u2013465 (2017).","journal-title":"J. Nucl. Med."},{"key":"24814_CR8","volume":"2017","author":"ER Fantoni","year":"2017","unstructured":"Fantoni, E. R. et al. Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7. EJNMMI Res. 2017, 7:31 (2017).","journal-title":"EJNMMI Res."},{"key":"24814_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/MNM.0000000000000660","volume":"38","author":"J Han","year":"2017","unstructured":"Han, J. et al. Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response. Nucl. Med. Commun. 38, 372\u2013382 (2017).","journal-title":"Nucl. Med. Commun."},{"key":"24814_CR10","first-page":"2374","volume-title":"ACS Chem. Neurosci.","author":"SM Wilkinson","year":"2017","unstructured":"Wilkinson, S. M. et al. Pharmacological evaluation of novel bioisosteres of an adamantanyl benzamide P2X7 receptor antagonist. ACS Chem. Neurosci. 8, 2374\u20132380 (2017)."},{"key":"24814_CR11","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1016\/j.bmcl.2003.08.034","volume":"13","author":"A Baxter","year":"2003","unstructured":"Baxter, A. et al. Hit-to-Lead Studies: The Discovery of Potent Adamantane Amide P2X7 Receptor Antagonists. Bioorg. Med. Chem. Lett. 13, 4047\u20134050 (2003).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"24814_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1124\/jpet.106.111559","volume":"319","author":"P Honore","year":"2006","unstructured":"Honore, P. et al. A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino)methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat. J. Pharmacol. Exp. Ther. 319, 1376\u20131385 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"24814_CR13","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1021\/jm8015848","volume":"52","author":"A Perez-Medrano","year":"2009","unstructured":"Perez-Medrano, A. et al. Discovery and Biological Evaluation of Novel Cyanoguanidine P2X7 Antagonists with Analgesic Activity in a Rat Model of Neuropathic Pain. J. Med. Chem. 52, 3366\u20133376 (2009).","journal-title":"J. Med. Chem."},{"key":"24814_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1021\/ml400040v","volume":"4","author":"MA Letavic","year":"2013","unstructured":"Letavic, M. A. et al. Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists. ACS Med. Chem. Lett. 4, 419\u2013422 (2013).","journal-title":"ACS Med. Chem. Lett."},{"key":"24814_CR15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/bph.12314","volume":"170","author":"A Bhattacharya","year":"2013","unstructured":"Bhattacharya, A. et al. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567. Br. J. Pharmacol. 170, 624\u2013640 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"24814_CR16","unstructured":"Adams, S.E. Molecular Similarity and Xenobiotic Metabolism. Ph.D. Thesis, University of Cambridge, Cambridge, U.K., (2010)."},{"key":"24814_CR17","unstructured":"MetaPrint2D-React, http:\/\/www-metaprint2d.ch.cam.ac.uk\/metaprint2d-react (accessed December 28 2017)."},{"key":"24814_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak, H., Alafuzoff, I., Arzberger, T., Kretzscmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389\u2013404 (2006).","journal-title":"Acta Neuropathol."},{"key":"24814_CR19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s004010000284","volume":"101","author":"M Mittelbronn","year":"2001","unstructured":"Mittelbronn, M., Dietz, K., Schluesener, H. J. & Meyerman, R. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol. 101, 249\u2013255 (2001).","journal-title":"Acta Neuropathol."},{"key":"24814_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1034-z","volume":"14","author":"W Beaino","year":"2017","unstructured":"Beaino, W. et al. Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis. J. Neuroinflammation 14, 259 (2017).","journal-title":"J. Neuroinflammation"},{"key":"24814_CR21","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2967\/jnumed.110.084426","volume":"52","author":"C Vandeputte","year":"2013","unstructured":"Vandeputte, C. et al. A PET brain reporter gene system based on type 2 cannabinoid receptors. J. Nucl. Med. 52, 1102\u20131109 (2013).","journal-title":"J. Nucl. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24814-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24814-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24814-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:42:10Z","timestamp":1671597730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24814-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24814"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24814-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]},"assertion":[{"value":"31 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6580"}}